[Establishing Individualized Medicine for Intractable Cancer Based on Clinical Molecular Pathogenesis]

Area of Science:

• Oncology
• Molecular Pathology
• Cancer Therapeutics

Background:

• Molecular-targeted agents have advanced cancer treatment, but patient selection and efficacy prediction remain difficult.
• Intratumoral heterogeneity significantly impacts patient response to targeted therapies.
• Oral squamous cell carcinoma (OSCC) is a prevalent head and neck cancer requiring tailored treatment approaches.

Purpose of the Study:

• To review the pathogenesis of oral squamous cell carcinoma (OSCC).
• To introduce novel therapeutic strategies based on clinical molecular pathogenesis.
• To highlight the need for individualized medicine in OSCC treatment.

Main Methods:

• Literature review focusing on OSCC molecular pathogenesis.
• Analysis of current challenges in targeted cancer therapy.
• Discussion of approaches for developing novel anticancer therapies.

Main Results:

• Intratumoral heterogeneity complicates the efficacy of molecular-targeted agents.
• Precise molecular pathological analysis is crucial for effective patient stratification.
• Understanding OSCC pathogenesis offers insights into treatment resistance and response.

Conclusions:

• A deeper understanding of molecular pathogenesis is essential for advancing OSCC treatment.
• Individualized medicine strategies are required to overcome treatment challenges in OSCC.
• Novel therapeutic approaches based on molecular insights hold promise for improving patient outcomes.